SCHEMBL893513

SCHEMBL893513

BCB

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3045849 0.82
SCHEMBL10179416 0.71
SCHEMBL12199389 0.71
SCHEMBL13937029 0.71
SCHEMBL595900 0.61
SCHEMBL10168121 0.61
SCHEMBL10019296 0.61
SCHEMBL8271429 0.61
SCHEMBL8216260 0.61
SCHEMBL8216255 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113443915-A Method for preparing ternary rare earth diboron-carbon ceramic powder 中国科学院金属研究所 2021-09-28 CN claimed
CN-107814570-B Method for preparing ternary rare earth diboron-carbon ceramic powder by boron/carbon thermal reduction method 中国科学院金属研究所 2020-08-21 CN claimed
CN-107285771-B Preparation method of ternary rare earth diboron-carbon ceramic material 中国科学院金属研究所 2020-07-10 CN claimed
EP-3908601-B1 COMPOSITIONS FOR TREATING CANCER OMEROS CORP (US) 2025-12-24 EP disclosed
US-20240307537-A1 Methods and Compositions for Treating Cancer OMEROS CORPORATION 2024-09-19 US disclosed
US-20240240047-A1 BIOMEDICAL DEVICES HAVING A SURFACE COATING JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT 2024-07-18 US disclosed
US-20240239788-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-07-18 US disclosed
US-20240018101-A1 MULTIVALENT TERPENE-BASED BOLAAMPHIPHILES FOR GENE DELIVERY UNIVERSITY OF SAN DIEGO 2024-01-18 US disclosed
US-11827657-B2 Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof Boehringer Ingelheim Animal Health USA Inc. (US) 2023-11-28 US disclosed
US-20230321083-A1 Inhibitors of GPR174 and Uses Thereof OMEROS CORP (US) 2023-10-12 US disclosed
CN-116352835-A Carbon-based composite ceramic and preparation method thereof 西安交通大学 2023-06-30 CN disclosed
EP-1280807-B1 PHOTOCHROMATIC PYRANO-1,3-OXAZINONAPHTHALENE DERIVATIVES ACOMON AG (CH) 2008-05-07 EP disclosed
EP-1130036-B1 Use of a composition for the preparation of a bulkhead of a thin display panel MITSUBISHI HEAVY IND LTD (JP) 2008-04-09 EP disclosed
US-20080050747-A1 Articles having localized molecules disposed thereon and methods of producing and using same PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2008-02-28 US disclosed
US-20070299068-A1 Methods for treating hepatitis C PTC THERAPEUTICS, INC. 2007-12-27 US disclosed
US-7297449-B2 Optical recording medium and optical recording apparatus KABUSHIKI KAISHA TOSHIBA (JP) 2007-11-20 US disclosed
US-7280176-B2 Liquid crystal display having a modified electrode array SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-10-09 US disclosed
EP-1832578-A1 METHOD FOR PRODUCING THIOCARBAMATE DERIVATIVE ZENYAKU KOGYO KABUSHIKI KAISHA (JP) 2007-09-12 EP disclosed
US-7262294-B2 Photochromatic pyrano-1,3-oxazinonaphthalene derivatives GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 2007-08-28 US disclosed
WO-2007048190-A1 MACROMOLECULAR COMPOUNDS HAVING CONTROLLED STOICHIOMETRY STARPHARMA PTY LIMITED (AU) 2007-05-03 WO disclosed